Reversal of new-onset type 1 diabetes with an agonistic TLR4/MD-2 monoclonal antibody

Kyle J. Bednar, Hiroki Tsukamoto, Kritika Kachapati, Shoichiro Ohta, Yuehong Wu, Jonathan D. Katz, Dana P. Ascherman, William M. Ridgway

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Reversal of new-onset type 1 diabetes with an agonistic TLR4/MD-2 monoclonal antibody'. Together they form a unique fingerprint.

Medicine & Life Sciences